Dysregulation of Hepatic Superoxide Dismutase, Catalase and Glutathione Peroxidase in Diabetes: Response to Insulin and Antioxidant Therapies

Clinical and Experimental Hypertension

Volumn 26, Issue 1, 2004, Pages 43-53

  Sindhu, Ram K ^a   Koo, Ja Ryung ^a,b   Roberts, Christian K ^a,c   Vaziri, Nosratola D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Hallym University   (South Korea)

^c CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Catalase; Diabetes; Glutathione peroxidase; Hyperglycemia; Oxidative stress; Reactive oxygen species; Streptozotocin; Superoxide dismutase

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; INSULIN ZINC SUSPENSION; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; DISEASE ASSOCIATION; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME REGULATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; WEIGHT REDUCTION;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CATALASE; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; GLUTATHIONE PEROXIDASE; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; LIVER; MALE; MALONDIALDEHYDE; MODELS, CARDIOVASCULAR; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME;

EID: 1342346794     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-120027330     Document Type: Article

References (35)

1. Mates JM, Perez-Gomez C, NunezDeCastro I. Antioxidant enzymes and human diseases. Clin Biochem 1999; 32:595-603.
2. Low PA, Nickander KK. Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 1991; 40:873-877.
3. Jennings PE, Jones AF, Florkowski CM, Lunec J, Barnett AH. Increased diene conjugates in diabetic subjects with microangiopathy. Diabet Med 1987; 4:452-456.
4. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, van Ypersole de SC, Monnier VM, Witztum JL, Kurokawa K. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest 1997; 100:2995-3004.
5. Nishikawa T, Edelstein D, Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Inter, Suppl 2000; 77:S26-S30.
6. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001; 44:129-146.
7. Mohan IK, Das UN. Oxidant stress, antioxidants and nitric oxide in non-insulin dependent diabetes mellitus. Med Sci Res 1997; 25:55-57.
8. Tuzun S, Girgin FK, Sozmen EY, Mentes G, Ersoz B. Antioxidant status in experimental type 2 diabetes mellitus: effects of glibenclamide and glipizide on various rat tissues. Exp Toxicol Pathol 1999; 51:436-441.
9. Maritim AC, Sanders RA, Watkins JB III. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17:24-38.
10. Vaziri ND. Pathogenesis of lead-induced hypertension: role of oxidative stress. J Hypertens, Suppl 2002; 3:S15-S20.
11. Vaziri ND, Ni Z, Oveisi F, Tarnavsky-Hobbs DL. Effect of antioxidant therapy on blood pressure and nitric oxide synthase expression in hypertensive rats. Hypertension 2000; 36:423-429.
12. Vaziri ND, Oveisi F, Ding Y. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int 1998; 53:1748-1754.
13. Roberts CK, Vaziri ND, Wang XQ, Barnard RJ. Enhanced NO inactivation and hypertension induced by a high-fat, refined carbohydrate diet. Hypertension 2000; 36:423-429.
14. Roberts CK, Vaziri ND, Sindhu RK, Barnard RJ. A high-fat, refined-carbohydrate diet affects renal NO synthase protein expression and salt sensitivity. J Appl Physiol 2003; 94:941-946.
15. Ritz E, Fliser D, Nowicki M. Hypertension and vascular disease as complications of diabetes. In: Laragh JV, Brenner BM, eds. Hypertension Diagnosis, Pathophysiology and Management. 2nd ed. New York, NY: Raven Press Ltd., 1995; 2321-2334.
16. Koo JR, Ni Z, Oviesi F, Vaziri ND. Antioxidant therapy potentiates antihypertensive action of insulin in diabetic rats. Clin Exp Hypertens 2002; 24:333-344.
17. Koo JR, Vaziri ND. Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. Kidney Int 2003; 63:195-201.
18. Claiborne A. Catalase activity. In: Greenwald RA, ed. Handbook of Methods for Oxygen Free Radical Research.: Boca Raton, FL: CRC Press, 1985; 283-284.
19. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002; 23:599-622.
20. Adachi T, Ohta H, Hayashi K, Hirano K, Marklund SL. The site of nonenzymic glycation of human extracellular superoxide dismutase in vitro. Free Radic Biol Med 1992; 13:205-210.
21. Sies H, Sharov VS, Klotz LO, Briviba K. Glutathione peroxidase protects against peroxynitrite-mediated oxidations: a new function for selenoproteins as peroxynitrite reductase. J Biol Chem 1997; 272:27812-27817.
22. Aragno M, Tamagno E, Gatto V, Brignardello E, Parola S, Danni O, Boccuzzi G. Dehydroepiandrosterone protects tissues against oxidative stress. Free Radic Biol Med 1999; 26:1467-1474.
23. 10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001; 15:41-46.
24. Sanders RA, Rauscher FM, Watkins JB. Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001; 15:143-149.
25. Rauscher FM, Sanders RA, Watkins JB III. Effects of new antioxidant compounds PNU-104067F and PNU-74389G on antioxidant defense in normal and diabetic rats. J Biochem Mol Toxicol 2000; 14:189-194.
26. Rauscher FM, Sanders RA, Watkins JB III. Effects of piperine on antioxidant pathways in tissues from normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2000; 14:329-334.
27. Rauscher FM, Sanders RA, Watkins JB III. Effects of isoeugenol on oxidative stress pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001; 15:159-164.
28. Mekinova D, Chorvathova V, Volkovova K, Staruchova M, Grancicova E, Klvanova J, Ondreicka R. Effect of intake of exogenous vitamins C, E and β-carotene on the antioxidative status in kidneys of rats with streptozotocin-induced diabetes. Nahrung 1995; 39:257-261.
29. Maritim AC, Moore BH, Sanders RA, Watkins JB III. Effects of melatonin on oxidative stress in streptozotocin-induced diabetic rats. Int J Toxicol 1999; 18:161-166.
30. Oberley LW. Free radicals and diabetes. Free Radic Biol Med 1988; 5:113-124.
31. Saxena AK, Srivastava P, Kale RK, Baquer NZ. Impaired antioxidant status in diabetic rat liver. Effect of vanadate. Biochem Pharmacol 1993; 45:539-542.
32. Jang YY, Song JH, Shin YK, Han ES, Lee CS. Protective effect of boldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats. Pharmacol Res 2000; 42:361-371.
33. Searle AJ, Wilson RL. Glutathione peroxidase: effect of superoxide, hydroxyl and bromine free radicals on enzyme activity. Int J Radiat Biol Relat Stud Phys Chem Med 1980; 37:213-217.
34. Bravenboer B, Kappelle AC, Hamers FPT, Van Buren T, Erkelens DW, Gispen WH. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia 1992; 35:813-817.
35. Caballero F, Gerez E, Batlle A, Vasquez E. Preventive aspirin treatment of streptozotocin induced diabetes: blockage of oxidative status and revertion of heme enzymes inhibition. Chem Biol Interact 2000; 126:215-225.